Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease - NCT00855855-37066 (Clinical Trial 275848)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy275848.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Gallatin |
|
State:
|
|
TN |
| Zip Code: |
|
37066 |
| Conditions: |
|
Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis |
| Purpose: |
|
To monitor the occurrence of invasive Hib disease over time and to determine
product-specific rates of invasive Hib disease within the monitored population.
|
| Study summary: |
|
The purpose of the study is to conduct surveillance for Hib disease.
Prospective active population-based surveillance for invasive Hib disease, conducted by the
Center for Disease Control and Prevention (CDC) Active Bacterial Core (ABCs) program within
geographic regions currently representing 12% of the US population, will provide Hib
case-occurrence (numerator) data.
The ABCs program and the National Center for Health Statistics will provide annual estimates
of the number of persons under surveillance, by age group, within the ABCs catchment area.
Ongoing telephone sample surveys, conducted by M/A/R/C, a national sampling organization,
will provide brand-specific vaccine exposure data by age group within the ABCs program
catchment area at appropriate pre-specified intervals (denominator data). |
| Criteria: |
|
Inclusion Criteria:
- Residence within the geographic scope of Active Bacterial Core surveillance (ABCs)
during the period of surveillance
- Aged 0 through 59 months (prior to 5th birthday) on the day of inclusion for Hib
disease surveillance and 2 through 23 months (prior to 2nd birthday) for Hib vaccine
brand usage survey.
- 2009-2014 calendar years inclusive.
- For the Hib vaccine usage survey, agreement to complete the required survey.
Exclusion Criteria:
Not applicable. |
|
|
|
| Study is available at: |
|
Gallatin, TN 37066
United States
Primary Contact:
Public Registry Sanofi Pasteur
Email: RegistryContactUs@sanofipasteur.com |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|